← Open Payments lookup

EMILY SHANAFELT: Open Payments

NPI 1437694080 · ROY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$575 in 33 payments from 20 companies in 2025. Trend: 2023 $690 · 2024 $781 · 2025 $575

Food & beverage: $575
CompanyPaymentsAmount
GlaxoSmithKline, LLC.4$76
PFIZER INC.3$59
Merck Sharp & Dohme LLC2$44
SANOFI-AVENTIS U.S. LLC2$43
Astellas Pharma US Inc2$40
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$37
Janssen Pharmaceuticals, Inc2$29
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$29
Dynavax Technologies Corporation2$27
Seqirus USA Inc1$23

Products named: TRELEGY ELLIPTA, NURTEC ODT, TZIELD, Veozah, CAPLYTA, SPRAVATO, XIFAXAN, Heplisav-B.

Industry payments across UT — which companies pay providers there.